(S (NP-SBJ-COOD (NP Acetylsalicylic/JJ acid/NN) and/CC (NP sodium/NN salicylate/NN)) (VP inhibit/VBP (NP (NP-COOD (NP LPS-induced/JJ NF-kappa/NN B\/c-Rel/NN nuclear/JJ translocation/NN) ,/, and/CC (NP (NP synthesis/NN) (PP of/IN (NP-COOD (NP (NP tissue/NN factor/NN) (PRN -LRB-/-LRB- (NP TF/NN) -RRB-/-RRB-)) and/CC (NP (NP tumor/NN necrosis/NN factor/NN alfa/NN) (PRN -LRB-/-LRB- (NP TNF-alpha/NN) -RRB-/-RRB-)))))) (PP in/IN (NP human/JJ monocytes/NNS)))) ./.)
(S (NP-SBJ We/PRP) (VP have/VBP (VP investigated/VBN (NP (NP the/DT effects/NNS) (PP of/IN (NP-COOD (NP acetylsalicylic/JJ acid/NN) and/CC (NP sodium/NN salicylate/NN))) (PP on/IN (NP (NP-COOD (NP (NP the/DT LPS-induced/JJ synthesis/NN) (PP of/IN (NP-COOD (NP the/DT pro-coagulant/JJ protein/NN (NP (NP tissue/NN factor/NN) (PRN -LRB-/-LRB- (NP TF/NN) -RRB-/-RRB-))) and/CC (NP the/DT pro-inflammatory/JJ protein/NN (NP (NP tumor/NN necrosis/NN factor-alpha/NN) (PRN -LRB-/-LRB- (NP TNF-alpha/NN) -RRB-/-RRB-)))))) ,/, (CONJP as/RB well/RB as/IN) (NP the/DT prostaglandin/NN PGE2/NN)) (PP in/IN (NP human/JJ monocytes/NNS))))))) ./.)
(S (NP-SBJ Both/DT drugs/NNS) (ADVP dose-dependently/RB) (VP-COOD (VP inhibited/VBD (NP (NP LPS-induced/JJ (NP-COOD (NP TF/NN) and/CC (NP TNF-alpha/NN)) synthesis/NN) (PP at/IN (NP (NP-COOD (NP the/DT mRNA/NN (NP *RNR*-32/-NONE-)) and/CC (NP the/DT protein/NN (NP *RNR*-32/-NONE-))) (NP-32 level/NN))))) ,/, and/CC (VP reduced/VBD (NP PGE2/NN production/NN))) ./.)
(S (SBAR As/IN (S (NP-SBJ-33 */-NONE-) (VP evidenced/VBN (NP *-33/-NONE-) (PP by/IN (NP-LGS-COOD (NP (NP electro/NN mobility/NN shift/NN assay/NN) (PRN -LRB-/-LRB- (NP EMSA/NN) -RRB-/-RRB-)) and/CC (NP (NP the/DT use/NN) (PP of/IN (NP a/DT NF-kappa/NN B/NN prototypic/JJ probe/NN)))))))) ,/, (NP-SBJ these/DT drugs/NNS) (ADVP probably/RB) (VP exert/VBP (NP their/PRP$ inhibitory/JJ effects/NNS) (PP by/IN (NP (NP interference/NN) (PP with/IN (NP (NP the/DT nuclear/JJ translocation/NN) (PP of/IN (NP NF-kappa/NN B\/c-Rel/NN proteins/NNS))))))) ./.)
(S (NP-SBJ These/DT data/NNS) (VP may/MD (VP expand/VB (NP (NP the/DT understanding/NN) (PP of/IN (NP (NP the/DT (ADJP-COOD (ADJP anti-thrombotic/JJ) and/CC (ADJP anti-inflammatory/JJ)) effects/NNS) (PP of/IN (NP these/DT drugs/NNS)) (SBAR-TMP (WHADVP-34 when/WRB) (S (NP-SBJ (NP activation/NN) (PP of/IN (NP monocytes/NNS))) (VP occurs/VBZ (ADVP *T*-34/-NONE-))))))))) ./.)
